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Abstract 
The effect of lysophosphatidic acid (LPA) on the preimplantation development of mouse embryos was examined. The blastocyst rates from 2-cell 
and 4-cell stage embryos were significantly higher in the presence of LPA at the pronuclear stage. However, the blastocyst rate from 4-cell stage 
embryos was significantly lower when LPA was added to the medium at the 4-cell stage than when it was added at the pronuclear stage. Furthermore, 
pretreatment of pronuclear stage embryos with pertussis toxin suppressed LPA-induced embryo developmenf suggesting that it is probably mediated 
by a Gi-protein-linked receptor. 
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1. Introduction 
Lysophosphatidic acid (LPA) is a naturally occurring 
phospholipid and a key intermediate in the pathway of 
synthesis of glycerophospholipids in many kinds of ani- 
mal cells. It is also present as a vasopressor in incubated 
plasma of mammals in which it is generated from lyso- 
phosphatidylcholine by the action of phospholipase D 
PI. 
LPA is known to have other biological activities such 
as platelet aggregation [2,3], smooth muscle contraction 
[4], stimulation of DNA synthesis and proliferation of 
fibroblasts [5-71 and evocation of an inward Cl- current 
in Xenopus Zuevis oocytes [8-lo]. Tigyi and Miledi [l l] 
identified albumin-bound LPAs in human serum as ac- 
tive components for induction of Ca*+-activated Cl- cur- 
rent in Xenopus laevis oocytes and of neurite retraction 
in PC 12 cells. Recently the effects of LPA on oocytes 
were suggested to be mediated by a specific membrane 
receptor linked to a pertussis toxin (PT) sensitive Gi- 
protein [lo]. However, the influence of LPA on embryo 
development has not been clarified. 
In this study, we examined the effect of LPA on the 
preimplantation development of ICR x ICR mouse em- 
bryos obtained by fertilization in vitro. 
*Corresponding author. Fax: (81) (886) 31 2630. 
Abbreviations: Basic CM, Whittingham’s T6 medium supplemented 
with 0.4% bovine serum albumin; hCG, human chorionic gona- 
dotropin; LPA, lysophosphatidic acid; PT, pertussis toxin. 
2. Materials and methods 
2.1. Superovulation and in vitro fertilization 
Ovulated eggs were obtained from 5-week-old female ICR strain 
mice (CD-l, Japan Charles River Co., Yokohama) and epididymal 
spermatozoa from 8-week-old male ICR mice (CD-I, Japan Charles 
River). The female mice were induced to superovulate by intraperi- 
toneal injection of 5 IU pregnant mare serum gonadotropin (Teikoku 
Hormone MFG Co., Tokyo) and 48 h later of 5 IU human chorionic 
gonadotropin (hCG) (Teikoku Hormone MFG). The oocytes were 
recovered 15 h after hCG injection and placed in 0.3 ml of Whitting- 
ham’s T6 medium supplemented with 0.4% bovine serum albumin 
(Sigma Chemical Co., St. Louis, MO) under paraffin oil. This medium 
is referred to basic CM. Sperm pellets obtained from the epididymides 
were placed in 0.3 ml of basic CM under 5% CO1 in humidified air for 
1.5 h. The oocytes were inseminated with motile spermatozoa (S- 
10 x lo4 cells/ml) and cultured in 0.3 ml of basic CM under paraffin oil 
for 5d h. Fertilization was assessed by noting the presence of two 
pronuclei and a second polar body. 
2.2. Effect of LPA on embryo development 
A stock solution of 1.0 mM oleoyl-LPA (Sigma) was prepared in 
phosphate-buffered saline with 1% bovine serum albumin, and kept at 
- 20°C until use. 
Mouse embryos were incubated in basic CM for 6 h after insemina- 
tion. Pronuclear stage embryos were then transferred into fresh basic 
CM with and without various concentrations of LPA (lo-*, IO-‘, lo-& 
or lo-’ M) and incubated for 90 h. Development of the preimplantation 
embryos was examined every 24 h under a dissection microscope. The 
rates of development from the pronuclear, 2-cell and 4-cell stage, re- 
spectively, to blastocysts (blastocyst rates) were compared. 
For determination of the relationship between the effect of LPA and 
the stage of embryonic development, lo-’ M of LPA was added tobasic 
CM at the pronuclear stage or the 4-tell stage. Pronuclear stage em- 
bryos were selected 6 h after insemination and divided into 3 groups. 
As a control, the first group was cultured continuously in basic CM 
under 5% CO1 in humidified air for 90 h. The second group was 
cultured in basic CM containing IO-’ M of LPA under the same condi- 
tions as the first group for 90 h. The third group was cultured in fresh 
basic CM for 42 h, and then 4-cell embryos were selected, and cultured 
further in basic CM containing 1O-5 M of LPA for 48 h. The blastocyst 
rates of the three groups were then compared. 
To demonstrate that a Gi-protein is involved in the embryo develop- 
ment stimulated with LPA, mouse embryos cultured in basic CM for 
6 h after insemination were then incubated with (2 groups) or without 
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Table 1 
Effect of LPA on mouse embryo development 
No. of pronuclear No. of 2-cell 
embryos embryos 
No. of embryos 
developing from 
2-cell to 4-cell stage 
No. of embryos 
developing from 
2-cell stage to 
blastocvsts 
39 
No. of embryos 
developing from 
4-cell stage to 
blastocvsts 
Basic CM (control) 
Basic CM + LPA (M) 
lo-* 
1 o-’ 
1 o-6 
1o-5 
115 101 48 (47.5) 17 (16.8) 17 (35.4) 
101 93 52 (55.9) 26 (28.0) 26 (50.0) 
96 88 38 (43.2) 22 (25.0) 22 (57.9)s 
99 92 39 (42.4) 24 (26.1) 24 (61.5)” 
128 117 63 (53.9) 38 (32.5)” 38 (60.3) 
Values in parentheses are percentages. 
“?Significantly different from control (‘P < 0.01, bP < 0.05). 
(2 groups) 200 ng/ml of PT (Funakoshi Co., Tokyo) for 18 h. Two-cell 
embryos were then selected and cultured in droplets of basic CM (con- 
trol or PT-treated) or basic CM containing 10m5 M of LPA (LPA- 
treated or PT+LPA-treated) under 5% CO, in humidified air for 72 h, 
and the blastocyst rates of the four groups were compared. 
2.3. Statistical analysis 
The chi-square test was used for statistical analysis. 
3. Results 
Mouse embryos were cultured for up to 90 h in basic 
CM with or without LPA (10-8-10-5M), and results are 
shown in Table 1. Therewas no significant difference in 
the rates of development of embryos from the pronuclear 
stage to the 4-cell stage in the five groups. However, 
32.5% of the 2-cell stage embryos developed to blasto- 
cysts when IO-‘M of LPA was added to the basic CM at 
the pronuclear stage, whereas only 16.8% did so in the 
absence of LPA (P < 0.01). Furthermore, the rates of 
development from the 4-cell stage to blastocysts were 
significantly higher in the presence of LPA (lo-‘, 10e6 or 
low5 M) than in its absence (P < 0.05). 
As shown in Table 2, the blastocyst rate from 4-cell 
stage embryos was 35.4% in the control group, and addi- 
tion of LPA (10m5 M) at the pronuclear stage increased 
the rate to 54.3%. However, addition of LPA at the 4-cell 
stage did not increase the blastocyst rateover that of the 
control group. 
Table 2 
Relationship between the embryonic stage and the stimulating effect of 
LPA 
No. of 4cell 
embryos 
Basic CM (control) 79 
Basic CM + LPA (rt-cell) 103 
Basic CM + LPA (pronuclear) 92 
Values in parentheses are percentages. 
“Significantly different from control (P c 0.05). 
No. of embryos 
developing from 
4-tell stage to 
blastocysts 
28 (35.4) 
39 (37.9) 
50 (54.3) 
When pronuclear stage embryos pretreated with PT 
were cultured in basic CMcontaining lob5 M of LPA, 
the blastocyst rates from the 2-cell and 4-cell stages 
were 16.3% and 38.5%, respectively. These rates were 
comparable with those of the control group and the 
group treated with PT alone, but were significantly lower 
than those of the group treated with LPA alone 
(Table 3). 
4. Discussion 
There are several reports of the significance of growth 
factors such as insulin [12-141 and insulin-like growth 
factor-l [12-141 and epidermal growth factor [15] in 
mouse embryo development. Other as yet unidentified 
growth factors may also be involved in embryo develop- 
ment. LPA is a newly discovered mitogen for fibroblasts 
[5-71 and an activator of Xenopus luevis oocytes [B-lo]. 
Recently we found that incubated human follicular fluid 
contained a considerable amount of LPA (unpublished 
observation). Therefore, in this study, we examined the 
effect of LPA on mouse embryo development. 
ICR x ICR mouse embryos obtained by fertilization 
in vitro tend to stop development at the 2-cell stage, a 
phenomenon named ‘Zcell-block’. This 2-cell-block is 
considered to be due to lack of vital components pro- 
duced by transcription from the embryonic genome or 
by synthesis from maternal messenger RNA [16]. In this 
study, we found that about 20% of 2-cell embryos es- 
caped 2-cell-block, developing to blastocysts in basic 
CM. Addition of LPA to the basic CM at the pronuclear 
stage significantly increased the blastocyst rate from the 
4-cell stage, but not the rate of development from the 
2-cell to 4-cell stage. These findings suggest hat the stim- 
ulating effect of LPA on mouse embryo development is 
not attributable to an effect in overcoming 2-cell-block. 
As LPA has been reported to stimulate DNA synthesis 
and proliferation of fibroblasts, it may act as a growth 
factor and may stimulate cell division of mouseembryos 
directly. 
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Table 3 
Effect of pertussis toxin on mouse embryo development stimulated by LPA 
No. of 2cell 
embryos 
No. of embryos developing No. of embryos developing No. of embryos developing 
from 2-cell to 4-cell stage from 2-cell stage to from 4-cell stage to 
blastocysts blastocysts 
Basic CM (control) 
Basic CM + LPA (10e5 M) 
+ PT (200 @ml) 
+ PT + LPA 
104 54 (5 I .9) 23 (22. I) 23 (42.6) 
III 61 (55.0) 39 (35.1)” 39 (63.9) 
98 47 (48.0) 26 (26.5) 26 (55.3) 
92 39 (42.4) 15 (16.3)b 15 (38.5)’ 
Values in parentheses are percentages. 
“Significantly different from control (P < 0.05). 
b.c Significantly different from the group treated with LPA alone (“P < 0.01, ‘P C 0.05). 
The finding that LPA significantly increased the blas- 
tocyst rate from the 4-cell stage, but not the rate from 
2-cell to 4-cell embryos (Table 1) suggested that it was 
not essential for the development of embryos from the 
pronuclear stage to the 4-cell stage. To examine this 
possibility, we added LPA to the culture medium at the 
pronuclear stage (Table 2), 2-cell stage (Table 3) and 
4-0~11 stage (Table 2), respectively, and compared the 
resulting blastocyst rates with that of control embryos. 
When LPA was added at the 4-cell stage, about 38% of 
the 4-cell embryos developed to blastocysts, and this 
value was comparable with that of the control group. 
However, when LPA was added for 90 h and 72 h from 
the pronuclear and 2-cell stage, respectively, the blasto- 
cyst rates were significantly higher. These results indicate 
that the presence of LPA from the 2-cell stage is neces- 
sary for its stimulating effect on mouse embryo develop- 
ment to blastocysts. 
Both the mitogenic action of LPA on fibroblasts [5] 
and its activating effect on oocytes [lo] are reported to 
be mediated througha Gi-protein or related PT sub- 
strate. In this study, we found that pretreatment of pro- 
nuclear stage embryos with PT for 18 h resulted in block 
of the effect of LPA on embryo development. This result 
clearly suggests that the stimulating effect of LPA on 
mouse embryo development is mediated by a Gi-protein- 
linked receptor. LPA is reported to initiate at least three 
separate signaling cascades [17]; (i) activation of a PT 
insensitive G-protein mediating phosphoinositide hy- 
drolysis coupled with both Ca” mobilization and activa- 
tion of protein kinase C, (ii) release of arachidonic acid 
in a GTP-dependent manner and (iii) activation of a 
PT-sensitive Gi-protein mediating inhibition of adenyl- 
ate cyclase. Recently, Fernhout et al. [8] suggested that 
an LPA-induced Ca*+-activated Cl- current in Xenopus 
laevis oocytes was mediated by a specific membrane re- 
ceptor linked to a PT-sensitive Gi-protein. Actually, a 
binding protein specific for LPA has been found in sev- 
eral kinds of cells (neuronal cells, brain homogenates, 
carcinoma cells, leukemic cells and normal fibroblasts). 
This binding protein was suggested to be linked to a 
PT-sensitive Gi-protein and considered to be a member 
of the superfamily of seven-transmembrane-domain re- 
ceptors [ 181. 
From our results and these reports, we conclude that 
LPA promotes the preimplantation development of 
mouse embryos and that its effect is probably mediated 
by a Gi-protein linked receptor on the surface of mouse 
embryos. 
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